Sanders Morris Harris’s Cue Biopharma CUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-346,212
| Closed | -$713K | – | 183 |
|
|
2023
Q3 | $713K | Buy |
346,212
+289,792
| +514% | +$597K | 0.15% | 106 |
|
|
2023
Q2 | $199K | Buy |
+56,420
| New | +$199K | 0.04% | 233 |
|
|
2023
Q1 | – | Sell |
-56,420
| Closed | -$161K | – | 173 |
|
|
2022
Q4 | $161K | Sell |
56,420
-791,628
| -93% | -$2.26M | 0.06% | 181 |
|
|
2022
Q3 | $2.02M | Buy |
848,048
+111,836
| +15% | +$266K | 0.49% | 31 |
|
|
2022
Q2 | $1.8M | Sell |
736,212
-136,809
| -16% | -$335K | 0.39% | 42 |
|
|
2022
Q1 | $4.26M | Buy |
873,021
+513,908
| +143% | +$2.51M | 0.83% | 23 |
|
|
2021
Q4 | $4.42M | Buy |
359,113
+53,381
| +17% | +$656K | 0.76% | 24 |
|
|
2021
Q3 | $4.1M | Buy |
305,732
+57,808
| +23% | +$776K | 0.75% | 25 |
|
|
2021
Q2 | $2.77M | Sell |
247,924
-104,610
| -30% | -$1.17M | 0.54% | 37 |
|
|
2021
Q1 | $4.39M | Buy |
352,534
+158,943
| +82% | +$1.98M | 0.93% | 24 |
|
|
2020
Q4 | $2.45M | Buy |
193,591
+51,161
| +36% | +$647K | 0.56% | 43 |
|
|
2020
Q3 | $2.31M | Buy |
+142,430
| New | +$2.31M | 0.63% | 38 |
|
|
2020
Q1 | – | Sell |
-69,750
| Closed | -$1.14M | – | 185 |
|
|
2019
Q4 | $1.14M | Buy |
+69,750
| New | +$1.14M | 0.26% | 97 |
|